Literature DB >> 32152731

Reduced exercise capacity and clinical outcomes following acute myocardial infarction.

Hiroshi Tashiro1,2, Akihito Tanaka3, Hideki Ishii1, Nariko Motomura2, Kenji Arai2, Takeshi Adachi2, Takashi Okajima2, Naoki Iwakawa1, Hiroki Kojima1, Takayuki Mitsuda1, Kenshi Hirayama1, Yusuke Hitora1, Motoharu Hayashi2, Kenji Furusawa1, Ruka Yoshida1, Hajime Imai2, Yasuhiro Ogawa2, Katsuhiro Kawaguchi2, Toyoaki Murohara1.   

Abstract

Reduced exercise capacity is known to be an important predictor of poor prognosis and disability in patients with cardiovascular diseases and chronic heart failure, and even members of the general population. However, data about exercise capacity assessed by cardiopulmonary exercise testing (CPX) in acute myocardial infarction (AMI) patients who underwent primary percutaneous coronary intervention (PCI) is scarce. Among 594 consecutive AMI patients who underwent primary PCI, we examined 136 patients (85.3% men, 64.9 ± 11.9 years) who underwent CPX during hospitalization for AMI. CPX was usually performed 5 days after the onset of AMI. Reduced exercise capacity was defined as peak VO2 ≤ 12. Clinical outcomes including all-cause death, myocardial infarction, and hospitalization due to heart failure were followed. Among 136 patients, reduced exercise capacity (peak VO2 ≤ 12) was seen in 38 patients (28%). Patients with reduced exercise capacity were older, more likely to have hypertension, and had lower renal function. In echocardiography, patients with reduced exercise capacity had higher E/e' and larger left atrial dimension. Multivariate logistic analysis showed that E/e' (OR 1.19, 95% CI 1.09-1.31, p < 0.001) was an independent predictor of reduced exercise capacity (peak VO2 ≤ 12). Median follow-up term was 12 months (IQR 9-22). The occurrence of composite endpoints of all-cause death, myocardial infarction, and hospitalization due to heart failure was significantly higher in patients with peak VO2 ≤ 12 than those with peak VO2 > 12 (p < 0.001). Reduced exercise capacity following primary PCI in AMI patients is associated with diastolic dysfunction and may lead to poorer clinical outcomes.

Entities:  

Keywords:  Acute myocardial infarction; CPX; Exercise capacity

Mesh:

Year:  2020        PMID: 32152731     DOI: 10.1007/s00380-020-01576-2

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  3 in total

1.  Prognostic value of leucine/phenylalanine ratio as an amino acid profile of heart failure.

Authors:  Hiroaki Hiraiwa; Takahiro Okumura; Toru Kondo; Toshiaki Kato; Shingo Kazama; Yuki Kimura; Toshikazu Ishihara; Etsuo Iwata; Masafumi Shimojo; Sayano Kondo; Soichiro Aoki; Yasunori Kanzaki; Daisuke Tanimura; Hiroaki Sano; Yoshifumi Awaji; Sumio Yamada; Toyoaki Murohara
Journal:  Heart Vessels       Date:  2021-01-22       Impact factor: 2.037

2.  Patient Perceptions of Exertion and Dyspnea With Interleukin-1 Blockade in Patients With Recently Decompensated Systolic Heart Failure.

Authors:  Virginia Mihalick; George Wohlford; Azita H Talasaz; Ai-Chen Jane Ho; Francine Kim; Justin M Canada; Salvatore Carbone; Dinesh Kadariya; Hayley Billingsley; Cory Trankle; Marco Giuseppe Del Buono; Francesco Moroni; Ross Arena; Antonio Abbate; Benjamin Van Tassell
Journal:  Am J Cardiol       Date:  2022-04-25       Impact factor: 3.133

3.  MiR-223-3p affects myocardial inflammation and apoptosis following myocardial infarction via targeting FBXW7.

Authors:  Libin Zhang; Jing Yang; Ming Guo; Minghui Hao
Journal:  J Thorac Dis       Date:  2022-04       Impact factor: 2.895

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.